SAN DIEGO, Aug. 14, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered national news coverage on NBC News’TODAY Show for its cannabidiol (CBD) body care products.
“We are honored to have one of our expertly formulated CBD body care products featured on such a prominent national news outlet,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We hope that this type of exposure can help educate and clear up the many misconceptions about cannabis and CBD.”
An Aug. 9, 2018, NBC News’ TODAY Show segment entitled, “CBD Oil is on the Rise: What to Know About the Marijuana Ingredient” discussed the potential therapeutic benefits of CBD in several different delivery methods. The segment also offered important education on what CBD is, where is it available, and provided examples of the rising acceptance of CBD in the U.S., including the FDA’s recent approval of a CBD-based pharmaceutical medication.
Medical Marijuana, Inc. produces and distributes a wide variety of CBD products including tinctures, liquids, edibles and topical products. These products are all sourced from industrial hemp grown throughout Europe and are Triple Lab Tested® for potency and safety. Medical Marijuana, Inc. was the first company in the U.S. to sell CBD across state lines and international borders and the first to receive import permits from Latin American countries such as Mexico, Paraguay, Argentina and Brazil.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil. In addition, the company now produces legal Humulus-based products, which are considered GRAS and a “food ingredient”.
Public Relations Contact:
Chief Executive Officer CMW Media